Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Mymd Pharmaceuticals Inc MYMD

MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro... see more

Recent & Breaking News (NDAQ:MYMD)

Akers Biosciences Signs Agreement to Market Rapid Tests in India

GlobeNewswire May 16, 2014

Akers Biosciences Announces Its Financial Results for First Quarter 2014

GlobeNewswire May 14, 2014

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg

GlobeNewswire May 8, 2014

Akers Biosciences Signs Distribution Agreement for Infectious Disease and Cholesterol Rapid Tests in Middle East, Australia, & Singapore

GlobeNewswire May 7, 2014

Akers Biosciences Starts Clinical Trials for PIFA PLUSS Chlamydia Assay

GlobeNewswire April 30, 2014

30+ Leading Small-Cap Companies to Present at RedChip Global Online CEO Conference, April 23-24

GlobeNewswire April 21, 2014

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg

GlobeNewswire April 10, 2014

Lucosky Brookman LLP takes Akers Biosciences, Inc. Public on NASDAQ

PR Newswire April 3, 2014

Akers Biosciences Announces Its Financial Results for Fiscal 2013

GlobeNewswire March 28, 2014

Leading Medical Sales and Marketing Executive to Spearhead Akers Biosciences' Commercialization Strategy

GlobeNewswire March 27, 2014

Akers Biosciences Co-Founder and Executive Chairman to Assume Duties of President & CEO

GlobeNewswire March 12, 2014

Akers Biosciences, Inc. Announces Pricing of Public Offering of Common Stock and Listing on NASDAQ

Globe Newswire January 23, 2014